Literature DB >> 31420455

Neuronal Myocyte-Specific Enhancer Factor 2D (MEF2D) Is Required for Normal Circadian and Sleep Behavior in Mice.

Jennifer A Mohawk1,2, Kimberly H Cox1, Makito Sato2,3, Seung-Hee Yoo1, Masashi Yanagisawa2,3, Eric N Olson4, Joseph S Takahashi5,2.   

Abstract

The transcription factor, myocyte enhancer factor-2 (MEF2), is required for normal circadian behavior in Drosophila; however, its role in the mammalian circadian system has not been established. Of the four mammalian Mef2 genes, Mef2d is highly expressed in the suprachiasmatic nucleus (SCN) of the hypothalamus, a region critical for coordinating peripheral circadian clocks. Using both conventional and brain-specific Mef2d KO (Mef2d -/-) mouse lines, we demonstrate that MEF2D is essential for maintaining the length of the circadian free-running period of locomotor activity and normal sleep patterns in male mice. Crossing Mef2d -/- with Per2::luc reporter mice, we show that these behavioral changes are achieved without altering the endogenous period of the master circadian oscillator in the SCN. Together, our data suggest that alterations in behavior in Mef2d -/- mice may be the result of an effect on SCN output, rather than an effect on timekeeping within the SCN itself. These findings add to the growing body of evidence that MEF2 proteins play important roles in the brain.SIGNIFICANCE STATEMENT These studies are the first to show a role for MEF2 proteins in the brain outside of the hippocampus, and our findings suggest that these proteins may play diverse roles in the CNS. It is important to continue to build on our understanding of the roles of proteins acting in the SCN because SCN dysfunction underlies jet lag in humans and influences the response to shift work schedules, which are now known as risk factors for the development of cancer. Our work on MEF2D could be the basis for opening new lines of research in the development and regulation of circadian rhythms.
Copyright © 2019 the authors.

Entities:  

Keywords:  MEF2D; circadian; sleep

Mesh:

Substances:

Year:  2019        PMID: 31420455      PMCID: PMC6774416          DOI: 10.1523/JNEUROSCI.0411-19.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

1.  Loss of Goosecoid-like and DiGeorge syndrome critical region 14 in interpeduncular nucleus results in altered regulation of rapid eye movement sleep.

Authors:  Hiromasa Funato; Makito Sato; Christopher M Sinton; Laurent Gautron; S Clay Williams; Amber Skach; Joel K Elmquist; Arthur I Skoultchi; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2.

Authors:  Brad E Pfeiffer; Tong Zang; Julia R Wilkerson; Makoto Taniguchi; Marina A Maksimova; Laura N Smith; Christopher W Cowan; Kimberly M Huber
Journal:  Neuron       Date:  2010-04-29       Impact factor: 17.173

3.  Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients.

Authors:  Hua She; Qian Yang; Kennie Shepherd; Yoland Smith; Gary Miller; Claudia Testa; Zixu Mao
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

4.  Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription.

Authors:  Scott D Ryan; Nima Dolatabadi; Shing Fai Chan; Xiaofei Zhang; Mohd Waseem Akhtar; James Parker; Frank Soldner; Carmen R Sunico; Saumya Nagar; Maria Talantova; Brian Lee; Kevin Lopez; Anthony Nutter; Bing Shan; Elena Molokanova; Yaoyang Zhang; Xuemei Han; Tomohiro Nakamura; Eliezer Masliah; John R Yates; Nobuki Nakanishi; Aleksander Y Andreyev; Shu-ichi Okamoto; Rudolf Jaenisch; Rajesh Ambasudhan; Stuart A Lipton
Journal:  Cell       Date:  2013-11-27       Impact factor: 41.582

5.  Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis.

Authors:  Xiaoming Gong; Xiaoli Tang; Marcus Wiedmann; Xuemin Wang; Junmin Peng; Dong Zheng; Leslie A C Blair; John Marshall; Zixu Mao
Journal:  Neuron       Date:  2003-04-10       Impact factor: 17.173

6.  Postnatal Loss of Mef2c Results in Dissociation of Effects on Synapse Number and Learning and Memory.

Authors:  Megumi Adachi; Pei-Yi Lin; Heena Pranav; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2015-10-08       Impact factor: 13.382

Review 7.  Suprachiasmatic nucleus: cell autonomy and network properties.

Authors:  David K Welsh; Joseph S Takahashi; Steve A Kay
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

Review 8.  The genetics of mammalian circadian order and disorder: implications for physiology and disease.

Authors:  Joseph S Takahashi; Hee-Kyung Hong; Caroline H Ko; Erin L McDearmon
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

9.  The transcription factor Mef2 links the Drosophila core clock to Fas2, neuronal morphology, and circadian behavior.

Authors:  Anna Sivachenko; Yue Li; Katharine C Abruzzi; Michael Rosbash
Journal:  Neuron       Date:  2013-07-24       Impact factor: 17.173

10.  Circadian mutant Overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression.

Authors:  Sandra M Siepka; Seung-Hee Yoo; Junghea Park; Weimin Song; Vivek Kumar; Yinin Hu; Choogon Lee; Joseph S Takahashi
Journal:  Cell       Date:  2007-04-26       Impact factor: 41.582

View more
  2 in total

Review 1.  Recent advances in sleep genetics.

Authors:  John M Webb; Ying-Hui Fu
Journal:  Curr Opin Neurobiol       Date:  2020-12-25       Impact factor: 7.070

2.  Isoflurane post-conditioning contributes to anti-apoptotic effect after cerebral ischaemia in rats through the ERK5/MEF2D signaling pathway.

Authors:  Qingtong Zhang; Jiangwen Yin; Feng Xu; Jingwen Zhai; Jieting Yin; Mingyue Ge; Wenyi Zhou; Nian Li; Xinlei Qin; Yan Li; Sheng Wang
Journal:  J Cell Mol Med       Date:  2021-02-23       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.